Lv1
100 积分 2025-07-31 加入
Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study
20天前
已完结
Long-term tocilizumab therapy in patients with corticosteroid-resistant active moderate-to-severe thyroid eye disease
1个月前
已完结
The role of teprotumumab in chronic, clinically active thyroid eye disease
1个月前
已完结
Teprotumumab for Asymmetric Thyroid Eye Disease
1个月前
已关闭
Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease
2个月前
已完结
Rundle’s Curve: A Useful Construct That Does Not Fit All
3个月前
已关闭
Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve Revisited
3个月前
已完结
Graves’ Disease
4个月前
已完结
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
4个月前
已完结
IL-6 in Inflammation, Immunity, and Disease
4个月前
已完结
皖公网安备34019202002308
